Cargando…
Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19
BCG vaccination has beneficial off-target (“nonspecific”) effects on nonmycobacterial infections. On this premise, trials set out to investigate whether BCG provides off-target protection against coronavirus disease 2019 (COVID-19). A literature search identified 11 randomized “BCG COVID-19” trials,...
Autores principales: | Noble, Christie C A, Messina, Nicole L, Pittet, Laure F, Curtis, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640778/ https://www.ncbi.nlm.nih.gov/pubmed/37558650 http://dx.doi.org/10.1093/infdis/jiad316 |
Ejemplares similares
-
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers
por: Pittet, Laure F., et al.
Publicado: (2023) -
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022) -
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
por: Messina, Nicole L., et al.
Publicado: (2023) -
Safety of BCG vaccination and revaccination in healthcare workers
por: Villanueva, Paola, et al.
Publicado: (2023) -
Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy
por: Villanueva, Paola, et al.
Publicado: (2022)